RSV Infection and Neurodegenerative Diseases: A Hypothesis of Energy Metabolism Disruption via the Lung-Brain Axis

Zeping Liu, Yan Zhou, Mingming Qi, Fangyuan Ren, Yurong TanAging 2025 · DOI

TL;DR

This review proposes a novel hypothesis: Respiratory Syncytial Virus (RSV) infection may contribute to neurodegenerative diseases by disrupting cellular energy metabolism, particularly through the "lung-brain axis." The paper highlights the need for further research to validate this link and explore targeted metabolic interventions for prevention and treatment.

What Problem Does This Paper Address?

RSV is a common respiratory virus, typically causing mild illness in healthy individuals but posing a significant threat to infants and the elderly. While its respiratory effects are well-documented, emerging evidence suggests a potential link between RSV infection and neurodegenerative diseases like Alzheimer's and Parkinson's. The exact mechanisms behind this connection are not fully understood, but preclinical studies point to disruptions in cellular energy metabolism as a key factor. This paper aims to consolidate existing knowledge and propose a unifying hypothesis – the "energy metabolism disorder hypothesis" – to explain how RSV infection might trigger or exacerbate neurodegeneration via the lung-brain axis. It addresses the critical gap in understanding the molecular pathways involved and the need for more human-relevant research to bridge the gap between preclinical findings and clinical applications.

Methods

This paper is a comprehensive review of existing literature. It synthesizes findings from preclinical studies (in vitro and animal models) and clinical observations to build its hypothesis. The authors systematically review research on:

  • RSV's entry into the nervous system: This includes direct translocation, vagal nerve transmission, cytokine regulation, neuroendocrine signaling, and transmission through the peripheral nervous system.
  • RSV's impact on cellular energy metabolism: This focuses on mitochondrial dysfunction, glucose metabolism reprogramming, and the metabolic state of microglia and neurons.
  • The "lung-brain axis": This concept describes the bidirectional communication between the lungs and the brain, which RSV infection may exploit.

The review doesn't introduce new experimental methods but rather analyzes and integrates findings from various studies to propose a novel theoretical framework.

Datasets

Not discussed in the paper. This is a review article, not an empirical study with its own datasets.

Key Insights and Ideas

  • The "Lung-Brain Axis" as a Conduit: RSV's ability to travel from the lungs to the brain, potentially through olfactory pathways, the vagus nerve, or even by crossing the blood-brain barrier, is a crucial element. This axis allows respiratory infections to directly influence neurological health.
  • Energy Metabolism as the Central Node: The core hypothesis is that RSV disrupts cellular energy production (ATP generation) in neurons and microglia. This energy crisis is proposed to be the primary driver of neuroinflammation and subsequent neurodegeneration.
  • Mitochondrial Dysfunction is Key: RSV appears to directly impair mitochondria, the powerhouses of cells. This leads to reduced ATP production and increased production of reactive oxygen species (ROS), creating a damaging cycle.
  • Glucose Metabolism Hijacking: RSV can reprogram glucose metabolism in host cells, shifting towards glycolysis. While this might provide immediate energy for viral replication, it can lead to an unstable energy supply for neurons and microglia in the long run.
  • Microglia's Double-Edged Sword: Microglia, the brain's immune cells, are activated by RSV. While crucial for clearing pathogens, their overactivation, coupled with energy deficits, can lead to the release of damaging inflammatory molecules, exacerbating neuroinflammation.
  • Interspecies Differences Matter: The authors highlight that current research heavily relies on in vitro and mouse models. These models have limitations in fully recapitulating the complex human immune response and neurodegenerative processes, necessitating caution in direct translation.

Key Results

The paper doesn't present quantitative results from new experiments. Instead, it synthesizes qualitative findings from existing research:

  • Evidence of RSV in the CNS: RSV mRNA has been detected in cerebrospinal fluid (CSF) of patients with neurological issues, and viral components have been found in the brains of infected animal models.
  • RSV's Impact on Cellular Processes: Preclinical studies show RSV can induce mitochondrial autophagy, damage mitochondrial DNA, and disrupt calcium homeostasis, all contributing to mitochondrial dysfunction.
  • Metabolic Reprogramming: Studies indicate RSV promotes glycolysis in epithelial cells and microglia, potentially at the expense of oxidative phosphorylation.
  • Association with Neurological Complications: A small percentage of children hospitalized with RSV infection experience neurological complications, including encephalitis and seizures.

Limitations and Future Work

The authors acknowledge several significant limitations and propose future directions:

  • Limitations of Current Models:
    • In vitro models: Lack complex cellular interactions and systemic metabolic regulation.
  • Murine models: Exhibit interspecies differences in immune responses and microglial behavior, limiting direct clinical translatability. Direct intracranial inoculation in mice bypasses critical lung-brain axis processes.
  • Scarcity of Clinical Data: Large-scale epidemiological studies directly linking RSV infection to neurodegenerative diseases are lacking. Retrospective analyses are often confounded by factors like co-infections and socioeconomic disparities.
  • Gene-Environment Interactions: Existing models fail to capture the complex interplay of genetic factors (e.g., APOE ε4 genotype) and environmental influences in human neurodegeneration.

Future Work Recommendations:

  • Enhanced Epidemiological Research: Conduct large-scale studies to establish direct links between RSV infection and neurodegenerative diseases.
  • Detailed Molecular Pathway Characterization: Further elucidate the specific molecular mechanisms by which RSV disrupts energy metabolism.
  • Human-Relevant Models: Develop and utilize more sophisticated models, including human-derived organoids or postmortem brain tissue, to better understand RSV's impact.
  • Targeted Metabolic Interventions: Explore therapeutic strategies that target metabolic pathways, such as antioxidants or metabolic regulators, to mitigate RSV-induced neurotoxicity.
  • Comparative Studies: Investigate whether energy metabolism disruption is a unique signature of RSV or a common mechanism shared by other neurotropic respiratory viruses.
  • Multi-omics Approaches: Integrate metabolomics and proteomics with clinical datasets to validate pathway specificity and identify diagnostic biomarkers (e.g., CSF lactate, mitochondrial DNA mutations).

Summary updated

Abstract

Respiratory Syncytial Virus (RSV), primarily recognized as a respiratory pathogen, has emerged as a potential contributor to neurodegenerative diseases via the "lung-brain axis." Preclinical studies highlight RSV-induced energy metabolism dysfunction as a core pathological mechanism encompassing mitochondrial dysfunction, glucose metabolism reprogramming, and microglial metabolic polarization-critical gaps in clinical validation, molecular specificity, and translational relevance. This review addresses these limitations by advocating for enhanced epidemiological research, detailed molecular pathway characterization, and the integration of human-relevant models. Targeted metabolic interventions have been proposed, supported by recent mechanistic insights, to bridge the gap between hypotheses and therapeutic development.
BibTeX
@inproceedings{liu2025rsv,
  author = {Zeping Liu and Yan Zhou and Mingming Qi and Fangyuan Ren and Yurong Tan},
  title = {{RSV Infection and Neurodegenerative Diseases: A Hypothesis of Energy Metabolism Disruption via the Lung-Brain Axis}},
  booktitle = {Aging},
  year = {2025},
  doi = {10.14336/ad.2025.0534},
}
Figure